Global Infertility
Drugs Market, By Drug Type (Clomiphene citrate, Sex hormones,
Gonadotropins, Bromocriptine, Cabergoline, Imipramine, Letrozole, and
Metformin), By Route of Administration (Oral, Intravenous, Subcutaneous, and
Intramuscular), By Gender (Male and Female), By Distribution Channel (Hospital
Pharmacies, Retail Pharmacies and Online Pharmacies), and By Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was
valued at US$ 3.8 billion in 2017, and is projected to exhibit a CAGR of 5.8%
over the forecast period (2019 - 2026).
The infertility drugs market size
is expanding, owing to increasing research studies for development of breakthrough
drugs for the treatment of infertility. According to a research conducted in
Princeton University in 2018, researchers have identified a key protein in old,
poor-quality Caenorhabditis elegans (microscopic worm) eggs, which controls the
aging of gametes. Researchers successfully blocked this protein during the
fertile period of the worm (equivalent to woman’s fertility in thirties), and
extended egg viability beyond the normal span. If these protein could be
removed from human genes, that could represent a 3 to 6 year extension of
female fertility. Increasing awareness about reproductive health in the
population is also highly contributing to the infertility drugs market growth.
For instance, RESOLVE - The National Infertility Association organizes National
Infertility Awareness Week (NIAW) every year in the last week of April since
2010.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2665
The goal of the week is to raise
awareness about infertility in maximum population, to encourage advocacy for
insurance in infertility drugs, and help couples with infertility cope with
their disease. Browse 17 Market Data Tables and 12 Figures spread through 145
Pages and in-depth TOC on " Global Infertility Drugs Market, By Drug Type
(Clomiphene citrate, Sex hormones, Gonadotropins, Bromocriptine, Cabergoline,
Imipramine, Letrozole, and Metformin), By Route of Administration (Oral,
Intravenous, Subcutaneous, and Intramuscular), By Gender (Male and Female), By
Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online
Pharmacies) and By Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) - Global Forecast to 2026"
Furthermore, various
organizations are focused on launching new programs to help infertile couples.
For instance, in 2014, EMD Serono a subsidiary of Merck KGaA, Germany launched
its Compassionate Corps Program, a patient assistance program to provide fertility
medications for eligible U.S. veterans who were infertile due to a
service-related injury. The company provides selected IVF stimulation
medications at no charge for up to two IVF cycles per year. Moreover, Merck
KGaA partnered with Genea Biomedx in May 2015, securing global rights to
Genea's portfolio of fertility products.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/infertility-drugs-market-2665
Key Takeaways of the Infertility
Drugs Market:
The global infertility drugs
market is expected to expand at a CAGR of 5.8% during the forecast period
(2019–2026), owing to increasing research & development and new infertility
drug launches by companies.
Among the drug type, the
Clomiphene citrate segment is expected to hold major revenue share in 2026, as
it is the most effective drug to treat infertility. According to a study published
in National Centre for Biotechnology Information (NCBI) in 2012, a comparative
study on effectiveness of clomiphene citrate and tamoxifen in ovulation
induction in infertile women showed that women treated with Clomiphene citrate
showed 64% increase in pregnancy rate than the women treated with tamoxifen,
which showed only 40% increase in pregnancy rate.
Major players operating in the
global infertility drugs market include Merck & Co., Ferring
Pharmaceuticals, LIVZON Pharmaceutical Group Inc., AbbottLaboratories, Bayer
AG, and Zydus Pharmaceuticals.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2665
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to emerging
market trends, technologies, and potential absolute dollar opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
